Skip to main content
. 2020 Sep 25;178(2):215–238. doi: 10.1093/toxsci/kfaa143

Table 4.

Developmental Toxicity Endpoints and Cyp1a Expression Patterns Mediated by AHR2 From Morpholino Knockdown Studies

Xenobiotic Ligand Endpoints Mediated by Ligand x AHR2 Results of AHR2 Knockdown References
Polycyclic Aromatic Hydrocarbons (PAHs)
 Pyrene
  • Pericardial edema, cell death in the neural tube, anemia- Cyp1a protein expression

  • Prevention of morphological effects

  • Reduced vasculature expression

Incardona et al. (2005)
 Chrysene
  • Cyp1a protein expression

  • Prevention of epidermal expression

  • No change to vasculature expression

Incardona et al. (2005)
 Dibenzothiophene
  • Cyp1a protein expression

  • Reduction of weak vascular expression

  • No change to cardiotoxicity

Incardona et al. (2005)
 Phenanthrene
  • Cyp1a protein expression

  • Reduction of weak vascular expression

  • No change to cardiotoxicity

Incardona et al. (2005)
 Benz[a]anthracene (BAA)
  • Pericardial edema

  • Intracranial hemorrhage

  • Cyp1a protein expression

  • Reduction in prevalence of pericardial edema

  • Prevention

  • Reduction in ventricular myocardium and epidermis

  • No reduction in endocardial and other vascular endothelial Cyp1a protein induction

Incardona et al. (2006, 2011)
 Benzo[a]pyrene (BaP)
  • Pericardial edema

  • Cyp1a protein expression

  • Larval hyperactive swimming response

  • Partial protection

  • Loss of myocardial expression

  • No reduction in endocardial expression

  • Decreased larval swimming response

Cunha et al. (2020); Incardona et al. (2011); Knecht et al. (2017b)

 Benzo[k]fluoranthene

 

(BkF)

  • Cyp1a protein expression

  • Markedly reduced epidermal Cyp1a expression

  • No reduction in endocardial expression or pericardial edema

Incardona et al. (2011)
 Retene
  • Pericardial edema

  • Cyp1a protein expression

  • Prevalence and severity of pericardial edema lower

  • Reduced epidermal expression

  • No change to vascular expression

Scott et al. (2011)
 Benz(a)anthracene-7,12-dione (7,12-B[a]AQ)
  • Morphology malformations: axis, trunk, brain, yolk and pericardial edemas, circulation, eye and jaw malformations

  • Cyp1a protein expression

  • Prevention

  • Prevention of vasculature expression

Goodale et al. (2015); Knecht et al. (2013)
 1,9-Benz-10-anthrone (BEZO)
  • Morphology malformations: axis, trunk, brain, yolk and pericardial edemas, circulation, eye and jaw malformations

  • Prevention

Goodale et al. (2015)
 1,6-Dinitropyrene,
  • Cyp1a protein expression

  • Reduction in skin and vasculature

Chlebowski et al. (2017)
benzo[j]fluoranthene, dibenzo[a.h]pyrene, dibenzo[a,i]pyrene, and benzo[b]fluoranthene
  • Cyp1a protein expression

  • Reduction in vasculature and prevention of skin expression

Shankar et al. (2019)
6H-benzo[cd]pyren-6-one
  • Cardiotoxicity

  • Prevention

Cunha et al. (2020)
Other chemicals: mixtures, pharmaceuticals, indoles, and halogenated aromatic hydrocarbons
 PAH-containing soil extracts from a gasworks, a former wood preservation site, and a coke oven
  • Edema and viability

  • Decrease in edema occurrence, and increase in viability

Wincent et al. (2015)
Total particulate matter (cigarette smoke)
  • Several morphological endpoints, viability, hatching success

  • Reduction in morphological endpoints, increased viability and hatching success

Massarsky et al. (2016)
 Environmentally relevant PAH mixtures (“Supermix 3” and “Supermix 10”)
  • Cyp1a protein expression

  • Supermix 3: decrease invasculature expression and increase in liver expression

    —Supermix 10: persistence of both vasculature and liver expression

Geier et al. (2018b)
 BaP and 6H-benzo[cd]pyren-6-one
  • Cardiotoxicity (pericardial edema and string heart formation)

  • Prevention

Cunha et al. (2020)
 Cardiosulfa (sulfanomide drug)
  • Cardiotoxicity

  • Reduction

Ko and Shin (2012); Ko et al. (2009)
 Leflunomide
  • Cyp1a protein expression

  • Reduction

Goodale et al. (2012); O’Donnell et al. (2010)
 3,3’,4,4’,5-Pentachlorobiphenyl (PCB-126)
  • Cardiotoxicity and mortality

  • Reduction

Garner et al. (2013); Jonsson et al. (2007)
Monosubstituted isopropyl triaryl phosphate (mITP) (a major component of Firemaster 550, a flame retardant mixture)
  • Cyp1a protein expression

  • Reduction

Gerlach et al. (2014)
Paclobutrazol (fungicide)
  • Digestive tract toxicity

  • Reduction

Wang et al. (2015)
 Formylindolo[3,2-b]carbazole (FICZ)
  • Mortality, pericardial edema, circulatory failure

  • Prevention

Wincent et al. (2016)
 Phenanthroline
  • PAH-like toxicity

  • Reduction

Ellis and Crawford (2016)
 2,7-Dibromocarbazole and 2,3,6,7-tetrachlorocarbazole
  • TCDD-like developmental toxicity

  • Reduction

Fang et al. (2016)
3α,5α-tetrahydrocorticosterone (5α-THB)
  • Enhanced larval locomotor activity

  • Blocked enhancement

  • AHR2 knockdown did not block 5β-THB-induced enhanced larval locomotor activity

Wu et al. (2019)
 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)
  • Developmental toxicity (multiple endpoints)

  • Prevention

  • No change to inhibition of swim bladder inflation and mortality

See text

Measured endpoints that were not altered upon AHR2 knockdown.